Paglitaz (USED IN DIABETES) Uses, Dosage, Side Effects and more

Trade Name Paglitaz (USED IN DIABETES)
Generic Pioglitazone Hydrochloride
Type
Therapeutic Class
Manufacturer
Available Country Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share